台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
旭富 (4119)籌碼相關-永豐金-中壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-中壢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1000.00288.8085.80-2259-0.77%
2025/01/0900.00389.4388.50-3251-1.19%
2024/12/2600.00291.1591.00-2250-0.80%
2024/11/2900.00396.0396.20-3199-1.50%
2024/11/2500.00097.9097.6001870.00%
2024/11/2200.00297.8597.50-2181-1.10%
2024/11/2000.00798.0797.80-7172-4.05%
2024/11/18196.100.895.5096.000.21510.11%
2024/11/12293.8000.0094.3021231.62%
2024/11/1100.00193.9093.30-1112-0.89%
2024/09/2700.00189.7089.80-1135-0.74%
2024/09/19287.8000.0088.3021481.34%
2024/09/13287.0000.0087.1021551.29%
2024/09/09185.6000.0086.5011590.63%
2024/09/06186.7000.0086.5011590.63%
2024/08/30288.1500.0088.4021711.17%
2024/08/1900.001088.9189.00-10184-5.42%
2024/08/15388.8700.0088.8031881.59%
2024/08/14189.3000.0089.3011910.52%
2024/08/13289.7000.0089.5021981.01%
2024/08/12490.7000.0089.9042031.97%
2024/08/0800.000.390.4090.20-0.3204-0.15%
2024/08/0600.00588.1688.90-5218-2.29%
2024/07/050.391.3700.0091.300.32030.15%
2024/06/170.191.1000.0090.800.12080.05%
2024/06/06192.5000.0092.4012180.46%
2024/06/03292.1000.0092.4022310.87%
2024/05/310.192.4000.0092.000.12300.03%
2024/05/1000.001190.7790.90-11240-4.58%
2024/05/0900.00188.4088.50-1243-0.41%
2024/05/072.188.0100.0088.102.12420.86%
2024/05/06288.4000.0088.5022420.82%
2024/05/03188.4000.0088.5012420.41%
2024/05/02388.4300.0088.8032441.23%
2024/04/190.186.5000.0086.400.12540.04%
2024/04/1700.00487.7588.40-4249-1.60%
2024/04/15088.4000.0087.7002520.01%
2024/04/11089.0000.0088.9002610.00%
2024/04/011088.9000.0088.70102573.89%
2024/03/260.187.6000.0087.200.12600.04%
2024/03/25088.0000.0087.6002610.00%
2024/03/22087.7000.0087.6002650.00%
2024/03/200.187.8000.0087.600.12780.04%
2024/03/191088.1600.0087.90102803.56%
2024/03/18087.8300.0086.9002840.00%
2024/03/150.187.6000.0087.400.12850.04%
2024/03/141.287.8200.0087.201.22860.42%
2024/03/120.289.3000.0089.000.22780.07%
2024/02/2600.00192.0092.10-1283-0.35%
2024/02/220.291.8000.0091.300.22830.07%
2024/02/1900.000.191.8091.50-0.1285-0.04%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章